Sarcoid-Like Reaction Mimicking Metastatic Progression Following Pembrolizumab Exposure in Triple-Negative Breast Cancer: A Case Report

Sarcoid-like granulomatous reactions can mimic metastatic progression on 18F-FDG PET/CT after immune checkpoint inhibitor exposure. We report a 37-year-old woman with triple-negative invasive ductal breast carcinoma and radiologically suspected pulmonary metastases treated with gemcitabine, carboplatin, and pembrolizumab. Increased thoracic nodal uptake and new skeletal foci in March 2025 were interpreted as progression without tissue confirmation, prompting a switch to capecitabine. Subsequent PET/CT demonstrated discordant nodal, pulmonary, and osseous changes. In February 2026, ultrasound-guided supraclavicular lymph-node biopsy demonstrated non-necrotizing granulomatous inflammation without malignancy; cytokeratin AE1/AE3, acid-fast bacilli, and Grocott stains were negative. The findings were consistent with sarcoidosis or sarcoid-like inflammation at the sampled site, but the nature of unsampled lesions and the association with pembrolizumab remained uncertain. Capecitabine was continued under surveillance, while corticosteroids were withheld because of absent symptoms and no demonstrated organ-threatening involvement. August 2026 PET/CT demonstrated fluctuating nodal uptake, stable indeterminate pulmonary nodules, and no new FDG-avid focus suspicious for metastatic disease. At pulmonology follow-up in October 2026, she remained asymptomatic despite reduced DLCO (65% predicted); additional organ assessment was ongoing. This case highlights the importance and limitations of tissue confirmation in interpreting apparent progression after immunotherapy.

Authors

Institutions

Publication Details

Journal
Case Reports in Oncology
Published
2026-11-20
DOI
https://doi.org/10.1159/cro/abzag107
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sarcoid-Like Reaction Mimicking Metastatic Progression Following Pembrolizumab Exposure in Triple-Negative Breast Cancer: A Case Report

Khaled Murshed, Aya Alqattaa, Mohammed Alkhanafsa, Ahmed M. Abdalhadi et al.
2 links
Case Reports in Oncology
Sarcoidosis and Beryllium Toxicity Research
article

Sarcoid-Like Reaction Mimicking Metastatic Progression Following Pembrolizumab Exposure in Triple-Negative Breast Cancer: A Case Report

Khaled Murshed, Aya Alqattaa, Mohammed Alkhanafsa, Ahmed M. Abdalhadi, Jamil Wafi, Ra’ed Ababneh, Soud Deek
article en

Abstract

Sarcoid-like granulomatous reactions can mimic metastatic progression on 18F-FDG PET/CT after immune checkpoint inhibitor exposure. We report a 37-year-old woman with triple-negative invasive ductal breast carcinoma and radiologically suspected pulmonary metastases treated with gemcitabine, carboplatin, and pembrolizumab. Increased thoracic nodal uptake and new skeletal foci in March 2025 were interpreted as progression without tissue confirmation, prompting a switch to capecitabine. Subsequent PET/CT demonstrated discordant nodal, pulmonary, and osseous changes. In February 2026, ultrasound-guided supraclavicular lymph-node biopsy demonstrated non-necrotizing granulomatous inflammation without malignancy; cytokeratin AE1/AE3, acid-fast bacilli, and Grocott stains were negative. The findings were consistent with sarcoidosis or sarcoid-like inflammation at the sampled site, but the nature of unsampled lesions and the association with pembrolizumab remained uncertain. Capecitabine was continued under surveillance, while corticosteroids were withheld because of absent symptoms and no demonstrated organ-threatening involvement. August 2026 PET/CT demonstrated fluctuating nodal uptake, stable indeterminate pulmonary nodules, and no new FDG-avid focus suspicious for metastatic disease. At pulmonology follow-up in October 2026, she remained asymptomatic despite reduced DLCO (65% predicted); additional organ assessment was ongoing. This case highlights the importance and limitations of tissue confirmation in interpreting apparent progression after immunotherapy.

Case Reports in Oncology
Hamad Medical Corporation (QA)
Good health and well-being
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Sarcoid-Like Reaction Mimicking Metastatic Progression Following Pembrolizumab Exposure in Triple-Negative Breast Cancer: A Case Report — Khaled Murshed, Aya Alqattaa, et al. · Case Reports in Oncology (2026) | TGRS Research Map | TGRS